Twenty Curated Companies. One Theme. Two Continents.
Healthtech × Biology x AI
HealthTech Venture Pulse 2027 is co-organized by Sahlgrenska Science Park and UC Berkeley Gateway Accelerator, NVIDIA and Business Sweden. This time we'll bring together ten Swedish and ten American companies in Silicon Valley, to pitch in front of a room with curated investors.
In connection with NVIDIA GTC 2027, we are bringing together leading players from Sweden and the US to explore how the convergence of biotechnology and AI is creating new opportunities in life science.
This isn’t an open demo day. It’s a closed-door, invitation-only programme built for real conversations between investors and founders. There’s no fee to attend, and only selected companies pitch.
Request your personal invitation HERE
Carefully curated
The format is intentionally designed to to maximise the quality of interactions and business outcomes. Each edition of HealthTech Venture Pulse features a curated programme including:
Curated pitch sessions featuring high-quality presentations from 12+ Seed–Series A companies.
Relevant keynote speakers with experience from leading global healthtech markets.
Networking between investors and founders, and between investors exploring co-investment or syndication.
The opportunity
Our 2026 edition of HealthTech Venture Pulse brought together:
12 startups, selected from more than 60 nominations
Investors from 16 VC firms, 3 family offices, 8 angel groups, and a corporate VC
Representing more than €1.5 billion ($1.6 billion) in combined assets
Why a Sweden-US room
Swedish venture building
University and hospital spinouts, backed by evidence from Sweden’s national health registries
US scale
The world’s largest healthcare market, with the capital and buyers to grow
Together
Early-stage backers meet the investors who take companies to scale
For startups:
Direct access to specialized investors seeking to lead and syndicate rounds
Qualified feedback from investors and networking opportunities
Increased visibility in the Nordic and international healthtech ecosystem
For investors and partners:
Early access to selected investment-ready companies
High-quality deal flow in healthtech, medtech and digital health
Direct interaction with founders and possibility to experience the products with live demos
Networking and syndication opportunities with other global investors